 | Up a level |
Number of items: 1.
Smith, Tania, Hoyo-Vadillo, Carlos, Adom, Akosua Agyeman, Favari-Perozzi, Liliana, Gastine, Silke, Dehbi, Hakim-Moulay, Villegas-Lara, Beatriz, Mateos, Eduardo, Gonzalez, Yessica Sara Perez, Navarro-Gualito, Maria D et al (show 10 more authors)
(2022)
Favipiravir and/or nitazoxanide: a randomized, double-blind, 2x2 design, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE).
TRIALS, 23 (1).
583-.
